Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
3.070
-0.240 (-7.25%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Rezolute Employees
Rezolute had 71 employees as of June 30, 2025. The number of employees increased by 12 or 20.34% compared to the previous year.
Employees
71
Change (1Y)
12
Growth (1Y)
20.34%
Revenue / Employee
n/a
Profits / Employee
-$1,123,040
Market Cap
318.89M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Bicycle Therapeutics | 288 |
| Abeona Therapeutics | 226 |
| Cabaletta Bio | 156 |
| Nautilus Biotechnology | 130 |
| Foghorn Therapeutics | 106 |
| Surrozen | 44 |
| Inhibikase Therapeutics | 35 |
| DiaMedica Therapeutics | 35 |
RZLT News
- 4 days ago - Rezolute, Inc. Investigated by the Portnoy Law Firm - GlobeNewsWire
- 7 days ago - Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pediatric Endocrine Society (PES) Annual Meeting - GlobeNewsWire
- 5 weeks ago - FDA Review Puts Rezolute's Genetic Disorder Drug Path In Question - Benzinga
- 5 weeks ago - Rezolute Provides Update on its Congenital Hyperinsulinism Program Following FDA Meeting - GlobeNewsWire
- 7 weeks ago - INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute (RZLT) - PRNewsWire
- 7 weeks ago - Rezolute to Participate in the Citizens Life Sciences Conference - GlobeNewsWire
- 2 months ago - RZLT SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - GlobeNewsWire
- 2 months ago - RZLT INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - PRNewsWire